SCHEMBL4446476

SCHEMBL4446476

O=C1C(=O)N(C(F)(F)F)c2ccccc21

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CES1 P23141 10/20 0.52
▸ TTR P02766 1/20 0.52
▸ BCHE P06276 3/20 0.50
▸ TGM2 P21980 1/20 0.50
▸ ALDH1A1 P00352 6/20 0.48
▸ CES2 O00748 1/20 0.48
▸ GAA P10253 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ CHRM5 P08912 1/20 0.47
▸ ALDH3A1 P30838 4/20 0.44
▸ ALDH2 P05091 3/20 0.44
▸ CHRM1 P11229 1/20 0.44
▸ MAOA P21397 1/20 0.43
▸ MAOB P27338 1/20 0.43
▸ AGTR1 P30556 1/20 0.43
▸ PARK7 Q99497 1/20 0.42
▸ ACHE P22303 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30286815 1.00 CES1 (0.52) CES1TTRBCHETGM2ALDH1A1
SCHEMBL4439639 0.82 CES1 (0.46) CES1TTRBCHETGM2ALDH1A1
SCHEMBL28596589 0.81 CES1 (0.40) CES1TTRBCHETGM2ALDH1A1
SCHEMBL14516316 0.80 CES1 (0.57) CES1TTRBCHETGM2ALDH1A1
SCHEMBL30951959 0.77 CES1 (0.50) CES1TTRBCHETGM2ALDH1A1
SCHEMBL29258531 0.77 TRPA1 (0.40) CES1TTRALDH1A1
SCHEMBL2707925 0.76 POLB (0.43) CES1BCHECES2GAANPSR1
SCHEMBL17818354 0.72 CES1 (0.57) CES1TTRBCHETGM2ALDH1A1
SCHEMBL31492057 0.72 CES1 (0.57) CES1TTRBCHETGM2ALDH1A1
SCHEMBL7233659 0.72 CES1 (0.65) CES1BCHETGM2ALDH1A1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118125961-A 1- (4-Trifluoromethyl-benzyl) -isatin derivative and preparation method and application thereof 武汉大学人民医院(湖北省人民医院) 2024-06-04 — — CN disclosed
EP-2134692-A2 QUINOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR SELECTIN INHIBITION Wyeth a Corporation of the State of Delaware (US) 2009-12-23 — — EP disclosed
WO-2008121817-A2 QUINOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR SELECTIN INHIBITION WYETH (US) 2008-10-09 — — WO disclosed
EP-1682511-A2 METHODS AND COMPOSITIONS FOR SELECTIN INHIBITION Wyeth (US) 2006-07-26 — — EP disclosed
WO-2005047257-A2 METHODS AND COMPOSITIONS FOR SELECTIN INHIBITION WYETH (US) 2005-05-26 — — WO disclosed
EP-1363624-A2 FLUORO OXINDOLE DERIVATIVES AS MODULATORS OF KCNQ POTASSIUM CHANNELS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-11-26 — — EP disclosed
WO-2002066426-A2 FLUORO OXINDOLE DERIVATIVES AS MODULATORS OF KCNQ POTASSIUM CHANNELS BRISTOL-MYERS SQUIBB COMPANY (US) 2002-08-29 — — WO disclosed
CN-1076348-C 3-ketoindole derivates taken as potassium channels regulator BRISTOL MYERS SQUIBB CO LTD (US) 2001-12-19 — — CN disclosed
CN-1144800-A 3-ketoindole derivates taken as potassium channels regulator BRISTOL MYERS SQUIBB CO (US) 1997-03-12 — — CN disclosed
Send feedback